We are live on ! Find out more
CM

Crestline Management Portfolio holdings

AUM $46.3M
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
-14.15%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$766M
AUM Growth
-$67.6M
Cap. Flow
+$38.7M
Cap. Flow %
5.06%
Top 10 Hldgs %
43.14%
Holding
345
New
89
Increased
60
Reduced
44
Closed
124

Top Buys

Rank Stock Value
1
ZION icon
Zions Bancorporation
ZION
+$14.2M
2
MTB icon
M&T Bank
MTB
+$10.2M
3
VYX icon
NCR Voyix
VYX
+$9.56M
4
EGHT icon
8x8 Inc
EGHT
+$8.53M
5
AON icon
Aon
AON
+$8.05M

Top Sells

Rank Stock Value
1
AIG icon
American International
AIG
+$10.5M
2
FITB
Fifth Third Bancorp
FITB
+$9.88M
3
ENOV icon
Enovis
ENOV
+$8.75M
4
GT icon
Goodyear
GT
+$7.54M
5
JPM icon
JPMorgan Chase
JPM
+$6.57M

Sector Composition

Rank Sector Weight
1 Healthcare 33.09%
2 Financials 24.28%
3 Technology 12.27%
4 Industrials 8.46%
5 Materials 8.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VSAC
201
DELISTED
Vision Sensing Acquisition Corp. Class A Common Stock
VSAC
$150K 0.02%
15,000
– –
MUDS
202
DELISTED
Mudrick Capital Acquisition Corporation II Class A Common Stock
MUDS
$150K 0.02%
14,930
– –
GFX
203
DELISTED
Golden Falcon Acquisition Corp.
GFX
$146K 0.02%
14,814
– –
ENPC
204
DELISTED
Executive Network Partnering Corporation
ENPC
$127K 0.02%
12,689
-54,110
-81% -$538K
PMGM
205
DELISTED
Priveterra Acquisition Corp. II Class A Common Stock
PMGM
$112K 0.01%
+11,264
New +$112K
IRON icon
206
Disc Medicine
IRON
$2.94B
$104K 0.01%
2,057
-26
-1% -$1.15K
JOFF
207
DELISTED
JOFF Fintech Acquisition Corp. Class A Common Stock
JOFF
$101K 0.01%
10,300
– –
ARTE
208
DELISTED
Artemis Strategic Investment Corporation Class A Common Stock
ARTE
$99K 0.01%
+10,000
New +$99.7K
ASAQ
209
DELISTED
Atlantic Avenue Acquisition Corp
ASAQ
$99K 0.01%
10,000
– –
HOOK
210
DELISTED
HOOKIPA Pharma
HOOK
$91K 0.01%
5,553
-72
-1% -$1.19K
ASMB icon
211
Assembly Biosciences
ASMB
$498M
$89K 0.01%
3,543
-46
-1% -$1.06K
PBYI icon
212
Puma Biotechnology
PBYI
$404M
$80K 0.01%
28,205
-366
-1% -$910
MTCR
213
DELISTED
Metacrine, Inc. Common Stock
MTCR
$79K 0.01%
158,659
-2,055
-1% -$995
ADVM
214
DELISTED
Adverum Biotechnologies
ADVM
$78K 0.01%
6,485
-84
-1% -$880
SCPX
215
DELISTED
Scorpius Holdings, Inc.
SCPX
$74K 0.01%
7
– –
ADAP
216
DELISTED
Adaptimmune Therapeutics
ADAP
$67K 0.01%
39,489
-511
-1% -$878
SPPI
217
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$51K 0.01%
65,362
-847
-1% -$746
GRTX
218
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$45K 0.01%
34,305
-444
-1% -$760
APRE icon
219
Aprea Therapeutics
APRE
$7.68M
$36K ﹤0.01%
2,441
-32
-1% -$738
DNTH icon
220
Dianthus Therapeutics
DNTH
$5.84B
$31K ﹤0.01%
1,633
-21
-1% -$519
CABA icon
221
Cabaletta Bio
CABA
$437M
$23K ﹤0.01%
+21,881
New +$30.9K
ABNB icon
222
Airbnb
ABNB
$89.9B
– –
-12,243
Closed -$2.1M
ACA icon
223
Arcosa
ACA
$7.13B
– –
-100,000
Closed -$5.72M
ADBE icon
224
Adobe
ADBE
$99.5B
– –
-2,637
Closed -$1.2M
AIG icon
225
American International
AIG
$41.7B
– –
-166,931
Closed -$10.5M
7 8
9
10 11

Similar funds

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
RRC
Range Rock Capital Wellesley, Massachusetts $46.7M AUM
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
NPCM
New Paradigm Capital Management Great Falls, Virginia $46.8M AUM
FCM
Firsthand Capital Management San Jose, California $46.9M AUM 114.33% 1-Year Est. Return
EGI
EAM Global Investors Solana Beach, California $47.1M AUM 320.45% 1-Year Est. Return
IPHI
Inflection Point Holdings II New York $47.3M AUM
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Crestline Management's Q2 2022 Portfolio in Review

As of Q2 2022, Crestline Management held 345 positions worth $766M, down 8.1% from $834M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Crestline Management deployed $38.7M of net new capital in Q2 2022, opening 89 new positions and adding to 60 existing holdings. Its largest new stake was Zions Bancorporation: 250,000 shares worth $12.7M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Ameriprise Financial, an estimated $4.18M trimmed.

  • Crestline Management's largest Q2 2022 buy was Zions Bancorporation: 250,000 shares worth $12.7M.
  • Crestline Management added most to M&T Bank in Q2 2022, an estimated $10.2M increase.
  • Crestline Management's biggest Q2 2022 reduction was Ameriprise Financial, cutting an estimated $4.18M.
  • Crestline Management fully exited American International in Q2 2022, selling an estimated $10.5M.
  • Crestline Management's ten largest holdings make up 43% of its $766M portfolio in Q2 2022.
  • Crestline Management opened 89 new positions and closed 124 in Q2 2022.
  • Crestline Management's portfolio value fell 8.1% quarter-over-quarter to $766M.

Based on Crestline Management's 13F filing for Q2 2022, filed 12 Aug 2022.